HRT Financial’s Aurora Cannabis ACB Stock Holding History

HRT Financial’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,880	Closed	-$268K	–	3081
2021 Q3	$268K	Buy	+3,880	New	+$276K	﹤0.01%	2488
2020 Q2	–	Sell	-463	Closed	-$50K	–	1506
2020 Q1	$50K	Buy	+463	New	+$82.7K	﹤0.01%	642

Other funds holding ACB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

HRT Financial's ACB Position: Q2 2026 in Review

HRT Financial sold out of Aurora Cannabis (ACB) in Q2 2026, closing a stake of 41,524 shares — an estimated $135K sold.

HRT Financial first reported a position in ACB in Q4 2019 and held it in 12 quarters. The position peaked at $802K in Q1 2024. 149 funds tracked by Wall St. Rank hold ACB as of Q2 2026.

HRT Financial reported no remaining Aurora Cannabis position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 41,524 Aurora Cannabis shares in Q2 2026, an estimated $135K.
HRT Financial first reported a position in Aurora Cannabis in Q4 2019 and held it in 12 quarters.
HRT Financial's Aurora Cannabis position peaked at $802K in Q1 2024.
149 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.